2 August 2022
Latham & Watkins Represents Biorez, Inc. in Definitive Agreement to be Acquired by CONMED
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Navneeta Rekhi Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Ian Bushner | Latham & Watkins LLP | Partner | corporate | Boston/Chicago |
| Andrew Rondeau | Latham & Watkins LLP | Associate | corporate | Not stated |
| Katie Connelly | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jennifer Pepin | Latham & Watkins LLP | Partner | executive compensation | New York |
| Madeline Hong | Latham & Watkins LLP | Associate | executive compensation | Not stated |
| Katharine Moir | Latham & Watkins LLP | Partner | tax | Bay Area |
| Alex Farris | Latham & Watkins LLP | Associate | tax | Not stated |
| Betty Pang | Latham & Watkins LLP | Counsel | healthcare regulatory | Bay Area |
6 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 85m (US$85 million)
- What the figure measures
- Total transaction value
- Client
- Biorez, Inc.Sell-side
- Counterparties
- CONMED Corporation (Buy-side)